.png){kind=icon}
.png){kind=icon}
Return
Hypopituitarism
.png){kind=icon}
PRE
AI
DOI：10.1016/S0140-6736(16)30053-8.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Hypopituitarism refers to deficiency of one or more hormones produced by the anterior pituitary or released from the posterior pituitary. Hypopituitarism is associated with excess mortality, a key risk factor being cortisol deficiency due to adrenocorticotropic hormone (ACTH) deficiency. Onset can be acute or insidious, and the most common cause in adulthood is a pituitary adenoma, or treatment with pituitary surgery or radiotherapy. Hypopituitarism is diagnosed based on baseline blood sampling for thyroid stimulating hormone, gonadotropin, and prolactin deficiencies, whereas for ACTH, growth hormone, and antidiuretic hormone deficiency dynamic stimulation tests are usually needed. Repeated pituitary function assessment at regular intervals is needed for diagnosis of the predictable but slowly evolving forms of hypopituitarism. Replacement treatment exists in the form of thyroxine, hydrocortisone, sex steroids, growth hormone, and desmopressin. If onset is acute, cortisol deficiency should be replaced first. Modifications in replacement treatment are needed during the transition from paediatric to adult endocrine care, and during pregnancy.
Keywords:
GROWTH-HORMONE GH
QUALITY-OF-LIFE
FRACTIONATED STEREOTACTIC RADIOTHERAPY
NONFUNCTIONING PITUITARY-ADENOMAS
IPILIMUMAB-INDUCED HYPOPHYSITIS
INSULIN-INDUCED HYPOGLYCEMIA
CARDIOVASCULAR RISK-FACTORS
REPLACEMENT THERAPY
DEFICIENT ADULTS
CENTRAL HYPOTHYROIDISM
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
88.5
Papers:
5.4W
Citations:
34.8W